MedTrace Logo

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

NCT01057290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.

PURPOSE: This research study is looking at biomarkers in cell samples from young patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

protein expression analysis

OTHER

fluorescence activated cell sorting

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Michele S. Redell, MD, PhD · Texas Children's Cancer Center

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057290 on ClinicalTrials.gov